Overview
Ningna Weng practices practicing medicine in China.
Their clinical expertise encompasses Budd-Chiari Syndrome, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, and Mesenteric Venous Thrombosis.
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ningna Weng
Is Ningna Weng a top-rated expert for Budd-Chiari Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Ningna Weng is classified as an Experienced expert for Budd-Chiari Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ningna Weng participate in research or clinical trials?
Yes. Ningna Weng has published 22 articles and abstracts on conditions like Budd-Chiari Syndrome. You can view a list of Ningna Weng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Basal Cell Skin CancerWeng isExperienced. Learn about Basal Cell Skin Cancer.
- Budd-Chiari SyndromeWeng isExperienced. Learn about Budd-Chiari Syndrome.
- Mesenteric Venous Thrombosis
- Pancreatic CancerWeng isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal Adenocarcinoma